21 July 2020 Sytheon Patents Isosorbide Esters for Skin Diseases, Enters Dermatological Market Read more
17 June 2020 UC-Davis has published a placebo controlled clinical study benefits of Synoxyl® AZ Read more
27 February 2020 Sytheon Introduces Asyntra® CBD-Alt, A patent Pending Carefully Crafted CBD-Alternate Product Read more
21 January 2020 Sytheon Announces New Research of Synastol® TC – Resetting Skin’s Circadian Rhythm Read more
19 October 2019 Sytheon Announces Second Peer Reviewed Publication on Synoxyl® AZ in J Investigative Dermatology Read more
